AbbVie · 1 week ago
2026 Cellular Morphology Profiling Intern (PhD)
AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The Cellular Morphology Profiling Intern will work on generating morphological data and validating predictive models using techniques like DeepCell and Cell Painting, contributing to the development of predictive models for various applications.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Data Generation: Use DeepCell and Cell Painting to produce morphological data
Model Testing: Participate in testing and validating predictive models to ensure accuracy and reliability
Documentation and presentations: Record experimental procedures and share results with cross-functional teams
Qualification
Required
Currently enrolled in university, pursuing a PhD in Biology, Cellular Biology or other related field
Must be enrolled in university for at least one semester following the internship
Expected graduation date between December 2026 – July 2027
Immunofluorescence and imaging experience required
Cell culture experience required
Self-motivated, team-player and adaptable
Excellent communication skills
Preferred
Exposure to morphology profiling approaches (i.e. Cell Painting)
Proficiency in handling, analyzing, and interpreting high-dimensional datasets is a plus
Experience with image analysis software such as Cell Profiler or ImageJ
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-11
2026-01-09
2026-01-09
Company data provided by crunchbase